Our mission is to provide A window to the free accessible biomedical resources for your study and practice：The Journal of Experimental Medicine publishes important new advances in research areas that include but are not limited to: immunology, infectious disease, inflammation, hematopoiesis, cancer, stem cells, and vascular biology. The JEM has long been known for its emphasis on physiological mechanisms and has more recently championed basic research on human subjects.
The JEM is a leading life sciences journal withan ISI impact factor of 13.965,* placing it among the top publications in two ISI categories: Immunology and Research & Experimental Medicine. The journal’s articles also have lasting impact, with a cited half-life of seven years.
With an acceptance rate below 15%, the JEM remains one of the most selective biomedical journals. Researchers who submit their work to the JEM benefit from an average time-to-first-decision of <5 weeks for reviewed manuscripts and <10 days for non-reviewed manuscripts. The average time from acceptance to publication remains under eight weeks.